The purpose of this study is to determine the safety of transplanting human islet cells for
controlling hyperglycemia in brittle and/or complex patients with type 1 diabetes. In
addition, initial observations will be made with regards to the effectiveness of reversing
hypoglycemia with this treatment. The "Edmonton Protocol" of using specific anti-rejection
drugs without steroids is also being evaluated.